Uses
INDICATION AND USE Administration of Sodium Iodide I 123 is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology.
Source: US FDA prescribing information
Molecule
Sodium iodide i-123
Available on request
- Presentations
- 2
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Sodium iodide i-123 is a prescription medicine indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology. It is available as capsules for oral use. MedsAcross supplies Sodium iodide i-123 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- US FDA first approval
- 24 March 1976
- EU status
- Not recorded
- Orphan designation
- Not recorded
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Oral
- Dosage forms
- Capsule
- Identifiers
- UNII 29UKX3A616RxCUI 91531CAS 41927-88-2Q27254446
Clinical information
From the regulator-approved product information. Each section names its source.
Dosing overview
The recommended oral dose for the average patient (70 kg) is 3.7 to MBq (100-400 µCi). The lower part of the dosage range MBq (100 µCi) is recommended for uptake studies alone, and the higher part MBq (400 µCi) for thyroid imaging. The determination of I 123 concentration in the thyroid gland may be initiated at six hours after administering the dose and should be measured in accordance with standardized procedures. The patient dose should be measured by a suitable radioactive calibration system immediately prior to administration. The capsules can be utilized up to thirty hours after calibration time and date. Thereafter, discard the capsules in accordance with standard safety procedures. The user should wear waterproof gloves at all times when handling the capsules or container.
Source: US FDA prescribing information
Contraindications
To date there are no known contraindications to the use of Sodium Iodide I 123 capsules.
Source: US FDA prescribing information
Warnings and precautions
Females of childbearing age and children under 18 should not be studied unless the benefits anticipated from the performance of the test outweigh the possible risk of exposure to the amount of ionizing radiation associated with the test.
Source: US FDA prescribing information
Side effects
Although rare, reactions associated with the administration of Sodium Iodide isotopes for diagnostic use include, in decreasing order of frequency, nausea, vomiting, chest pain, tachycardia, itching skin, rash and hives.
Source: US FDA prescribing information
Storage
Store at room temperature, below 86°F.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
All presentations
2 presentations of Sodium iodide i-123, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Sodium iodide i-123 100 µCi capsuleOralGeneric name | — | US FDA | Available on request |
| Sodium iodide i-123 200 µCi capsuleOralGeneric name | — | US FDA | Available on request |
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 24 March 1976 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Questions and answers
Is Sodium iodide i-123 available for export from India?
Yes, on request. MedsAcross lists 2 presentations of Sodium iodide i-123 and sources them for licensed hospitals, importers and physicians against valid import documents.
Is Sodium iodide i-123 approved by the US FDA?
Yes. The US FDA first approved Sodium iodide i-123 on 24 March 1976, according to Drugs@FDA.
Does Sodium iodide i-123 need cold chain shipping?
No listed presentation of Sodium iodide i-123 is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
References
- Sodium Iodide I 123 prescribing information (Cardinal Health). U.S. National Library of Medicine, DailyMed. Retrieved 17 April 2018
Request Sodium iodide i-123 for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.